Supply Chain
Stryker aims to replace cord-and-console setups for extremities procedures with its F1 Small Bone Power System, a tool with five motors and two gripping styles.
The FDA expanded Johnson & Johnson's Acclarent Aera Eustachian Tube Balloon Dilation System's indication to now allow treatment in patients as young as 18 years old.
Alere agreed to pay $33.2 million to resolve False Claims Act allegations that it knowingly sold defective point-of-care diagnostic testing devices.
On the news Takeda was considering a bid for Shire, investors expressed their skepticism with their purchasing power, causing the company's stock to tumble 7 percent March 28, Reuters reports.
Medtronic plans to redeem about $1.2 billion of senior notes and buy back at least the same amount in ordinary shares throughout its 2019 fiscal year.
A cataract drug company that paid more than $1 million in 2017 to lobby lawmakers regained Medicare reimbursement status in hospital outpatient and ASC settings, the SF Chronicle reports.
McKesson highlighted key trends affecting the performance of the healthcare supply chain as the industry transitions to value-based care models.
Tenet Healthcare hit a new 52-week high when the stock traded as high as $25.19 per share.
Boston Scientific acquired NxThera, the privatelyheld company behind the Rezūm system.
Stryker Chairman, President and CEO Kevin Lobo was paid more than $14 million in 2017, three times what the company paid its second highest compensated executive and 209 times what its median employee made.